Swiss-Scandinavian Bio-Business Zurich 2016
| Reference number | |
| Coordinator | Redoxis AB - Redoxis AB, Lund |
| Funding from Vinnova | SEK 7 500 |
| Project duration | February 2016 - March 2016 |
| Status | Completed |
Important results from the project
Participation in Swiss- Scandinavian Bio- Business in Zurich in 2016 , February 10th for partnership with Europe Riska companies in order to identify customers and partners Redoxis / ProNoxis service CRO and drug development for the treatment of autoimmune diseases.
Expected long term effects
To perform a pitch presentation and direct appointments facilitated by the SSBBS portal to seek new customers to Redoxis CRO operations and identify and meet potential partners for both Redoxis CRO operations and subsidiary drug development company ProNoxis with the aim to create opportunities for new partnerships and applications to H2020 and Eurostars.
Approach and implementation
Participation in SSBBS meeting in Zurich contains the student Peter Olofsson different parts. 1)Listen to panel discussions on financing, partnerships and the development of the life science industry. 2)Network with organizations and companies 3)Pitch (5min) of Redoxis/ProNoxis focusing on new services for drug development and demonstrate the capacity and experience of the EU applications 4)partnerships in the form of 1 to 1 meetings